These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 32261210)
21. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer. Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677 [TBL] [Abstract][Full Text] [Related]
22. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery. Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060 [TBL] [Abstract][Full Text] [Related]
23. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells. Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666 [TBL] [Abstract][Full Text] [Related]
24. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release. Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495 [TBL] [Abstract][Full Text] [Related]
25. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study. Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748 [TBL] [Abstract][Full Text] [Related]
26. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior. Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411 [TBL] [Abstract][Full Text] [Related]
27. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Gong C; Wang C; Wang Y; Wu Q; Zhang D; Luo F; Qian Z Nanoscale; 2012 May; 4(10):3095-104. PubMed ID: 22535210 [TBL] [Abstract][Full Text] [Related]
28. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species. Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686 [TBL] [Abstract][Full Text] [Related]
29. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery. Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700 [TBL] [Abstract][Full Text] [Related]
30. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219 [TBL] [Abstract][Full Text] [Related]
31. Intracellularly Actuated Quantum Dot-Peptide-Doxorubicin Nanobioconjugates for Controlled Drug Delivery via the Endocytic Pathway. Sangtani A; Petryayeva E; Wu M; Susumu K; Oh E; Huston AL; Lasarte-Aragones G; Medintz IL; Algar WR; Delehanty JB Bioconjug Chem; 2018 Jan; 29(1):136-148. PubMed ID: 29191007 [TBL] [Abstract][Full Text] [Related]
32. Folate-decorated PEGylated triblock copolymer as a pH/reduction dual-responsive nanovehicle for targeted intracellular co-delivery of doxorubicin and Bcl-2 siRNA. Suo A; Qian J; Xu M; Xu W; Zhang Y; Yao Y Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():659-672. PubMed ID: 28482576 [TBL] [Abstract][Full Text] [Related]
33. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity. Deng L; Dong H; Dong A; Zhang J Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic effects of boronate ester cross-linked injectable hydrogels for the treatment of hepatocellular carcinoma. Jung JM; Kim SH; Giang Phan VH; Thambi T; Lee DS Biomater Sci; 2021 Oct; 9(21):7275-7286. PubMed ID: 34609388 [TBL] [Abstract][Full Text] [Related]
35. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging. Xiong D; Zhang X; Peng S; Gu H; Zhang L Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801 [TBL] [Abstract][Full Text] [Related]
36. Biocompatible and acid-cleavable poly(ε-caprolactone)-acetal-poly(ethylene glycol)-acetal-poly(ε-caprolactone) triblock copolymers: synthesis, characterization and pH-triggered doxorubicin delivery. Wang H; He J; Zhang M; Tao Y; Li F; Tam KC; Ni P J Mater Chem B; 2013 Dec; 1(48):6596-6607. PubMed ID: 32261268 [TBL] [Abstract][Full Text] [Related]
37. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer. Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916 [TBL] [Abstract][Full Text] [Related]
38. Self-stabilized silk sericin-based nanoparticles: In vivo biocompatibility and reduced doxorubicin-induced toxicity. Hu D; Li T; Xu Z; Liu D; Yang M; Zhu L Acta Biomater; 2018 Jul; 74():385-396. PubMed ID: 29783089 [TBL] [Abstract][Full Text] [Related]
39. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin. Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978 [TBL] [Abstract][Full Text] [Related]
40. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles. Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]